Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in Germany

Healthcare expenditure on pharmaceuticals and medical non-durable goods in Germany has demonstrated a fluctuating trend over the past decade. In 2013, spending was recorded at 14 units of total current health expenditure and, despite minor increases and decreases over the years, gradually declined to 13.81 units by 2023. The year-on-year variation over the last two years showed a slight decrease, while the last five-year CAGR reveals an average annual decrease of approximately 0.53%.

Looking into future trends, the forecasted data from 2024 to 2028 suggests a continued slight decline, with a CAGR of -0.03%, indicating a relatively stable yet slightly downward trend in expenditure. Key factors to watch for include changes in healthcare policies, pharmaceutical innovations, economic conditions, and demographic shifts that may influence healthcare funding allocations.